Accumulation of LC3-II and p62 has been observed in NASH patients [45], and the accumulation of LC3 and p62 was positively correlated with disease severity [45,46]. The gene discussed is MAP1LC3A; the disease is metabolic dysfunction-associated steatohepatitis.